Clinical trial · Interventional
ELobectomy for NSCLC by VATS Versus Thoracotomy (ECTOP-1007)
Lobectomy for Clincial Stage T1N0M0 Solid NSCLC by VATS Versus Thoracotomy
NCT03786003CI-TRIAL-00068163recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is one of Eastern Cooperative Thoracic Oncology Projects (ECTOP-1007). The goal of this study is to determine video-assisted thoracoscopic surgery is non-inferior to thoracotomy in terms of disease-free survival for solid clinical stage T1N0M0 NSCLC.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Carcinoma, Non-Small-Cell Lung | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Thoracotomy | Procedure | — | UNRESOLVED |
| VATS | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- VATS
- description
- Video-assisted thoracoscopic surgery
- interventionNames
- Procedure: VATS
- type
- ACTIVE_COMPARATOR
- label
- Thoracotomy
- description
- Open surgery
- interventionNames
- Procedure: Thoracotomy
Primary outcomes (1)
- measure
- Disease-free survival
- timeFrame
- 3 years after the surgery
- description
- Disease-free survival means the period after surgery when no disease can be detected.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Clinical stage T1N0M0 and surgical resectable. * Solid appearance on computed tomography scan. * Age 18 to 75 year. * Signed the informed consent form. Exclusion Criteria: * Not NSCLC in pathological analysis. * Not lobectomy or sublobar resection. * History of other malignant tumors within 5 years. * History of thoracic surgery or unsuitable for VATS. * Previous radiation or chemotherapy.
References
Publications (0)
Data not yet available
No reference posted for this study.